Nurix Therapeutics, Inc. (NRIX)
18.97
-0.05
(-0.26%)
USD |
NASDAQ |
Dec 31, 16:00
19.09
+0.12
(+0.63%)
After-Hours: 20:00
Nurix Therapeutics Market Cap: 1.458B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 152.28B |
| Pfizer Inc. | 141.57B |
| GT Biopharma, Inc. | 8.352M |
| Incyte Corp. | 19.39B |
| Regeneron Pharmaceuticals, Inc. | 81.12B |
Market Cap Related Metrics
| PS Ratio | 18.70 |
| PEG Ratio | -3.336 |
| Price to Book Value | 3.918 |
| Price | 18.97 |
| Earnings Yield | -15.64% |
| PEGY Ratio | -3.336 |